|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003873,
umls-concept:C0077503,
umls-concept:C0079189,
umls-concept:C0087111,
umls-concept:C0205195,
umls-concept:C0243077,
umls-concept:C0332307,
umls-concept:C0599779,
umls-concept:C0814225,
umls-concept:C1704264,
umls-concept:C1749467
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2000-12-28
|
|
pubmed:abstractText |
To determine the potential for additive or synergistic effects of combination therapy with the recombinant anticytokine agents interleukin-1 receptor antagonist (IL-1Ra) and PEGylated soluble tumor necrosis factor receptor type I (PEG sTNFRI) in established type H collagen-induced arthritis (CIA) and developing adjuvant-induced arthritis (AIA) in rats.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2648-59
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11145022-Animals,
pubmed-meshheading:11145022-Arthritis, Experimental,
pubmed-meshheading:11145022-Arthritis, Rheumatoid,
pubmed-meshheading:11145022-Cytokines,
pubmed-meshheading:11145022-Disease Models, Animal,
pubmed-meshheading:11145022-Dose-Response Relationship, Drug,
pubmed-meshheading:11145022-Drug Therapy, Combination,
pubmed-meshheading:11145022-Female,
pubmed-meshheading:11145022-Immunoglobulin G,
pubmed-meshheading:11145022-Interleukin 1 Receptor Antagonist Protein,
pubmed-meshheading:11145022-Male,
pubmed-meshheading:11145022-Rats,
pubmed-meshheading:11145022-Rats, Inbred Lew,
pubmed-meshheading:11145022-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:11145022-Sialoglycoproteins
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis.
|
|
pubmed:affiliation |
Amgen Colorado, Boulder, USA.
|
|
pubmed:publicationType |
Journal Article
|
